Short-term Administration of Glucagon-like Peptide-2. Effects on Bone Mineral Density and Markers of Bone Turnover in Short-Bowel Patients with No Colon

By Haderslev K. V.   Jeppesen P. B.   Hartmann B.   Thulesen J.   Sorensen H. A.   Graff J.   Hansen B. S.   Tofteng F.   Poulsen S. S.   Madsen J. L.   Holst J. J.   Staun M.   Mortensen P. B.  

Scandinavian Journal of Gastroenterology, Vol. 37, Iss. 4, 2002-04 ,pp. : 392-398

Informa Healthcare

Access to resources Recommend Favorite

Bone resorption is decreased postprandially by intestinal factors and glucagon-like peptide-2 is a possible candidate

By Holst Jens J.   Hartmann Bolette   Gottschalck Ida B.   Jeppesen Palle B.   Miholic Johannes   Henriksen Dennis Bang  

Scandinavian Journal of Gastroenterology, Vol. 42, Iss. 7, 2007-01 ,pp. : 814-820

Informa Healthcare

Access to resources Recommend Favorite

Reduction in bone resorption by exogenous glucagon-like peptide-2 administration requires an intact gastrointestinal tract

By Gottschalck Ida   Jeppesen Palle   Holst Jens   Henriksen Dennis  

Scandinavian Journal of Gastroenterology, Vol. 43, Iss. 8, 2008-01 ,pp. : 929-937

Informa Healthcare

Access to resources Recommend Favorite

Glucagon-like Peptide 2

By Drucker D.J.  

Trends in Endocrinology and Metabolism, Vol. 10, Iss. 4, 1999-05 ,pp. : 153-156

Elsevier

Access to resources Recommend Favorite

Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists in the Treatment of Obese Women with Polycystic Ovary Syndrome

By  

Current Vascular Pharmacology, Vol. 15, Iss. 3, 2017-04 ,pp. : 218-229

Bentham Science Publishers

Access to resources Recommend Favorite